GHRP-2 vs Ipamorelin
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A growth-hormone secretagogue peptide from the GHRP family—stronger GH pulse than ipamorelin, with more appetite stimulation.
GHRP-2 binds ghrelin receptors to trigger GH release from the pituitary. It is more potent than ipamorelin for GH output but often causes noticeable hunger. Like other GHRPs it is not FDA-approved for athletic or anti-ag…
GH release
A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs.
Ipamorelin binds ghrelin receptors and triggers pituitary GH release without strongly raising cortisol or prolactin. Clinics pair it with CJC-1295 for anti-aging and body-composition goals. Not FDA-approved for OTC use; …
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. GHRP-2 is categorized as GH release; Ipamorelin as GH release. GHRP-2: A growth-hormone secretagogue peptide from the GHRP family—stronger GH pulse than ipamorelin, with more appetite stimulation. Ipamorelin: A selective growth-hormone secretagogue peptide—stimulates GH with less appetite spike than older GHRPs.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.